What You Should Know:
- Elation Health, the clinical-first technology company powering innovation in primary care, today announced that its Clinical Insights solution has moved to Claude Haiku 4.5 by Anthropic, the leading artificial intelligence research and development company with an emphasis on responsible AI.
- Clinical Insights delivers summaries of a patient's health story to clinicians at the point of care, using Claude’s speed and long-context reasoning for safe, accurate
Read More
Archives for 2026
HealthEx and Anthropic Partner to Bring Personal Health Records Directly to Claude
What You Should Know
- HealthEx and Anthropic have launched a first-of-its-kind integration that allows Claude Pro and Max users to securely connect their medical records from over 50,000 provider organizations directly to the AI.
- The partnership leverages the federal TEFCA framework and a new Model Context Protocol (MCP) to provide personalized health summaries and lab interpretations while ensuring that sensitive patient data is never used for model training.
Bridging the
Read More
Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics
What You Should Know
- Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
- The partnership includes the development of an exclusive, purpose-built AI model trained on Lilly’s proprietary data, leveraging Chai's Chai-2 platform to compress discovery timelines from months to weeks.
The "Zero-Shot" Revolution: Slashing Discovery Timelines
In the world of biologics, antibody design has
Read More
Amazon Pharmacy Disrupts Weight Loss Market with Oral Wegovy: $149 Cash-Pay Option and Same-Day Delivery
What You Should Know
- Amazon Pharmacy has officially added Novo Nordisk’s Wegovy® pill—the first and only FDA-approved oral GLP-1 for weight management—to its nationwide delivery platform.
- To lower barriers to care, Amazon is offering a transparent cash-pay option starting at $149 per month for those without insurance, while eligible commercially insured customers may pay as little as $25.
The Oral Shift: Removing the Needle Barrier
The "Wegovy pill" represents a massive
Read More
The Flight to Quality: Why 2026 Healthcare VC is Betting on AI Integration Over Innovation
Venture capital is making a comeback in healthcare, and this time, artificial intelligence (AI) is at the center of the movement.
According to Crunchbase, funding for AI-powered health-tech startups surged to an estimated $10.7 billion in 2025, a 24% increase over the previous year. That represents roughly one-third of all digital-health investments this year, signaling not just a rebound from prior market corrections but a renewed focus on technologies that deliver measurable clinical
Read More
AccurKardia Secures Second FDA Clearance for AccurECG 2.0 to Tackle Cardiac Backlogs
What You Should Know
- AccurKardia has announced its second FDA 510(k) clearance for the AccurECG™ Analysis System (v2.0). This enterprise-grade, cloud-based platform is designed to ingest data from any ECG hardware—including patches and Holters—and deliver fully automated, near real-time interpretation for 13 rhythm classifications with 99% accuracy.
- As cardiac data volumes surge due to the proliferation of wearables, AccurECG 2.0 allows hospitals and independent diagnostic testing
Read More
Smarter Media Planning: How Pharma Marketers are Solving the 2026 FDA Compliance Gap
Pharma advertising is entering a period of accelerated change. As the Food and Drug Administration increases oversight of direct‑to‑consumer promotions, marketers are rethinking how they reach patients and consumers. New guidance aimed at improving risk communication and ensuring message accuracy is prompting brands to diversify their media strategies and invest in channels that balance reach, trust, and regulatory responsibility.
Marketers Are Reassessing the Full Advertising Mix
Spending
Read More
DiMe Launches Initiative to Scale Trusted AI Care Navigation
What You Should Know
- The Digital Medicine Society (DiMe) has launched a new multi-stakeholder initiative, "Scaling Trusted, High-Impact AI Care Navigation," to accelerate the responsible adoption of AI tools that help patients manage appointments, referrals, and insurance.
- Led by title sponsor Intel and a founding coalition of tech and healthcare leaders, the project will develop open-access resources to ensure AI-enabled care journeys are patient-centered, equitable, and
Read More
Rune Labs Names Tempus Veteran Amy Gordon Franzen as CEO to Scale AI Precision Medicine
What You Should Know
- Rune Labs, the leader in precision neurology, has appointed Amy Gordon Franzen as its new Chief Executive Officer.
- Franzen, a foundational leader from Tempus, joins as Rune Labs prepares to scale its StrivePD ecosystem beyond Parkinson’s Disease into Alzheimer’s and other dementias. Co-founder Brian Pepin will transition to President, Biopharma and Platform, focusing on the company’s expanding research portfolio and life sciences partnerships.
Bringing
Read More
Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence
What You Should Know
- Prescryptive and Ilant Health have partnered to offer employers a direct-to-market channel for GLP-1 therapies, combining transparent net pricing with rigorous clinical oversight.
- The collaboration utilizes Prescryptive’s claims platform and Ilant’s Center of Excellence (COE) model to deliver an average 15% weight loss for participants while ensuring that 90% of members remain on therapy at the six-month mark.
The Operating Model: Aligning Clinical Guardrails
Read More
